This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Beijing Sinohanfang Pharmaceutical Sci. & Tech Co., Ltd.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Meilin Wang - Innovator in Transdermal Drug Delivery Technology.
Introduction
Meilin Wang is a notable inventor based in Beijing, China. She has made significant contributions to the field of pharmaceutical technology, particularly in the development of transdermal drug delivery systems. Her innovative approach addresses critical challenges in drug administration, enhancing the efficacy and reliability of therapeutic treatments.
Latest Patents
Wang holds a patent for a transdermal drug delivering device. This invention provides a solution to the issues faced in prior art, where the absorptive force of an outer annular cavity caused by negative pressure was weakened, leading to the application disk falling off. The device comprises a first top, an annular outer wall, an annular inner wall, a first connecting tube, and a middle annular cavity. The design allows for adaptability to changes in curvature, ensuring that the application disk remains securely in place, even on uneven surfaces.
Career Highlights
Meilin Wang is currently associated with Beijing Sinohanfang Pharmaceutical Science & Technology Co., Ltd. Her work at this company has been instrumental in advancing drug delivery technologies. With her innovative mindset, she continues to push the boundaries of pharmaceutical science.
Collaborations
Wang collaborates with Gang Chen, a fellow innovator in the field. Their partnership exemplifies the importance of teamwork in driving forward advancements in pharmaceutical technology.
Conclusion
Meilin Wang's contributions to transdermal drug delivery systems highlight her role as a leading inventor in the pharmaceutical industry. Her innovative solutions are paving the way for more effective drug administration methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile